ICU Medical Stock Forecast for 2023 - 2025 - 2030
Updated on 04/26/2024
ICU Medical Stock Forecast and Price Target
ICU Medical's most recent price target of $136.50 for 2024 was provided by three renowned analysts over the past few months, with an average prediction of $136.50. If this prediction is correct, ICU Medical's stock could rise by 44.4 percent from its current trading price. The potential increase for the stock is $136.50 per share, with a possible range of $135.00 to $161.00. If you want to invest in ICUI stock, you might also want to take a look at how its competitors are doing.
44.40% Upside
ICU Medical Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, ICU Medical's Price has decreased by 100.00%, going from $183.74 to $0.00. The next year looks promising for ICU Medical, with analysts predicting Fair Value of $0.00 – an increase of 100.00%. Over the next seven years, experts anticipate that ICU Medical's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| JNJ Stock Forecast | Johnson & Johnson | Outperform |
9
|
$146.82 | Buy/Sell | $174.55 | 15.79% |
| DHR Stock Forecast | Danaher | Outperform |
10
|
$245.80 | Buy/Sell | $260.33 | 9.85% |
| ABT Stock Forecast | Abbott Laboratories | Outperform |
9
|
$106.86 | Buy/Sell | $118.92 | 18.38% |
| SIE Stock Forecast | Siemens | Outperform |
10
|
173.70€ | Buy/Sell | 178.14€ | 12.55% |
| SYK Stock Forecast | Stryker Corp | Outperform |
10
|
$337.15 | Buy/Sell | $353.16 | 8.71% |
ICU Medical Revenue Forecast for 2023 - 2025 - 2030
In the last three years, ICU Medical's Revenue has grown, increasing from $1.27B to $2.26B – a growth of 77.74%. The next year looks promising for ICU Medical, with analysts predicting Revenue of $2.31B – an increase of 2.29%. Over the next seven years, experts anticipate that ICU Medical's Revenue will grow at a rate of 9.87%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ETN Stock Forecast | Eaton | Outperform |
13
|
$317.10 | Buy/Sell | $246.22 | -1.61% |
| BSX Stock Forecast | Boston Scientific | Outperform |
11
|
$73.26 | Buy/Sell | $70.14 | 9.20% |
| MDT Stock Forecast | Medtronic | Outperform |
11
|
$79.25 | Buy/Sell | $92.47 | 20.50% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PH Stock Forecast | Parker-Hannifin Corp | Outperform |
10
|
$549.38 | Buy/Sell | $548.76 | 8.30% |
| BDX Stock Forecast | Becton Dickinson and Co | Outperform |
9
|
$230.48 | Buy/Sell | $284.47 | 21.49% |
| EW Stock Forecast | Edwards Lifesciences Corp | Outperform |
11
|
$88.01 | Buy/Sell | $91.18 | 10.21% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| WST Stock Forecast | West Pharmaceutical Services | Outperform |
18
|
$368.18 | Buy/Sell | $380.80 | 3.21% |
| 4543 Stock Forecast | Terumo | Outperform |
18
|
¥5.63k | Buy/Sell | ¥4.97k | -9.46% |
| 6594 Stock Forecast | Nidec | Outperform |
18
|
¥5.79k | Buy/Sell | ¥8.31k | 37.26% |
ICU Medical EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, ICU Medical's EBITDA has grown by 25.60%, rising from $220.23M to $276.61M. For next year, analysts predict EBITDA of $393.58M, which would mean an increase of 42.29%. Over the next seven years, experts predict that ICU Medical's EBITDA will grow at a rate of 108.41%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BAX Stock Forecast | Baxter International Inc | Outperform |
17
|
$40.23 | Buy/Sell | $44.86 | 11.86% |
| PHIA Stock Forecast | Koninklijke Philips N.V. | Hold |
18
|
19.27€ | Buy/Sell | 19.42€ | 1.19% |
| ABMD Stock Forecast | Abiomed | - |
16
|
$377.79 | Buy/Sell | $380.00 | -88.33% |
ICU Medical EBIT Forecast for 2023 - 2025 - 2030
In the last three years, ICU Medical has seen a decline in its EBIT, from $134.60M to $47.84M – a 64.46% decrease. For next year, analysts predict EBIT of $269.35M, which would mean an increase of 463.02%. Over the next seven years, experts predict that ICU Medical's EBIT will grow at a rate of 588.47%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| FRE Stock Forecast | Fresenius SE & Co. KGaA | Outperform |
18
|
27.18€ | Buy/Sell | 38.63€ | 26.93% |
| TFX Stock Forecast | Teleflex Inc | Hold |
13
|
$206.71 | Buy/Sell | $263.46 | 28.20% |
| ATR Stock Forecast | AptarGroup Inc | Outperform |
18
|
$140.18 | Buy/Sell | $135.80 | 4.87% |
ICU Medical EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, ICU Medical's EPS has decreased by 100.00%, going from $7.13 to $0.00. The next year looks promising for ICU Medical, with analysts predicting EPS of $-1.03 – an increase of 100.00%. Over the next seven years, experts anticipate that ICU Medical's EPS will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| WWD Stock Forecast | Woodward | Outperform |
18
|
$149.74 | Buy/Sell | $135.80 | 8.86% |
| CTEC Stock Forecast | ConvaTec Group PLC | Outperform |
16
|
£2.76 | Buy/Sell | £3.43 | 43.84% |
| BERY Stock Forecast | Berry Global Group | Outperform |
16
|
$56.55 | Buy/Sell | $73.36 | 30.86% |
.jpg)